Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health Network.

Law, Jeanna Wallenta; Mitra, Debanjali; Kaplan, Henry G; Alfred, Tamuno; Brufsky, Adam M; Emir, Birol; McCracken, Haley; Liu, Xianchen; Broome, Ronda G; Zhang, Chenan; DiCristo, Caroline; Chen, Connie

Law, Jeanna Wallenta; Mitra, Debanjali; Kaplan, Henry G; Alfred, Tamuno; Brufsky, Adam M; Emir, Birol; McCracken, Haley; Liu, Xianchen; Broome, Ronda G; Zhang, Chenan; DiCristo, Caroline; Chen, Connie.

Affiliation

Law JW; Syapse, San Francisco, CA 94107, USA.
Mitra D; Pfizer Inc., New York, NY 10017, USA.
Kaplan HG; Swedish Cancer Institute, Seattle, WA 98104, USA.
Alfred T; Pfizer Inc., New York, NY 10017, USA.
Brufsky AM; Comprehensive Breast Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Emir B; Pfizer Inc., New York, NY 10017, USA.
McCracken H; Syapse, San Francisco, CA 94107, USA.
Liu X; Pfizer Inc., New York, NY 10017, USA.
Broome RG; Syapse, San Francisco, CA 94107, USA.
Zhang C; Syapse, San Francisco, CA 94107, USA.
DiCristo C; Pfizer Inc., New York, NY 10017, USA.
Chen C; Pfizer Inc., New York, NY 10017, USA.

Curr Oncol ; 29(2): 1047-1061, 2022 02 12.

Article de En | MEDLINE | ID: mdl-35200588

Sujet(s)
Mots clés

HR+/HER2−; aromatase inhibitor; metastatic breast cancer; palbociclib; real-world data

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Inhibiteurs de l'aromatase Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans Langue: En Journal: Curr Oncol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google